GB0317509D0 - Nicotinamide derivatives useful as PDE4 inhibitors - Google Patents

Nicotinamide derivatives useful as PDE4 inhibitors

Info

Publication number
GB0317509D0
GB0317509D0 GBGB0317509.8A GB0317509A GB0317509D0 GB 0317509 D0 GB0317509 D0 GB 0317509D0 GB 0317509 A GB0317509 A GB 0317509A GB 0317509 D0 GB0317509 D0 GB 0317509D0
Authority
GB
United Kingdom
Prior art keywords
pde4 inhibitors
derivatives useful
nicotinamide derivatives
nicotinamide
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0317509.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GBGB0317509.8A priority Critical patent/GB0317509D0/en
Publication of GB0317509D0 publication Critical patent/GB0317509D0/en
Priority to JP2006520932A priority patent/JP2006528623A/en
Priority to PCT/IB2004/002365 priority patent/WO2005010001A1/en
Priority to CA002533681A priority patent/CA2533681A1/en
Priority to EP04744024A priority patent/EP1651647A1/en
Priority to BRPI0412933-4A priority patent/BRPI0412933A/en
Priority to MXPA06000988A priority patent/MXPA06000988A/en
Priority to US10/895,883 priority patent/US7153870B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB0317509.8A 2003-07-25 2003-07-25 Nicotinamide derivatives useful as PDE4 inhibitors Ceased GB0317509D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB0317509.8A GB0317509D0 (en) 2003-07-25 2003-07-25 Nicotinamide derivatives useful as PDE4 inhibitors
JP2006520932A JP2006528623A (en) 2003-07-25 2004-07-13 Nicotinamide derivatives useful as PDE4 inhibitors
PCT/IB2004/002365 WO2005010001A1 (en) 2003-07-25 2004-07-13 Nicotinamide derivatives useful as pdea4 inhibitors
CA002533681A CA2533681A1 (en) 2003-07-25 2004-07-13 Nicotinamide derivatives useful as pde4 inhibitors
EP04744024A EP1651647A1 (en) 2003-07-25 2004-07-13 Nicotinamide derivatives useful as pdea4 inhibitors
BRPI0412933-4A BRPI0412933A (en) 2003-07-25 2004-07-13 nicotinamide derivatives useful as pde4 inhibitors
MXPA06000988A MXPA06000988A (en) 2003-07-25 2004-07-13 Nicotinamide derivatives useful as pdea4 inhibitors.
US10/895,883 US7153870B2 (en) 2003-07-25 2004-07-20 Nicotinamide derivatives useful as PDE4 inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0317509.8A GB0317509D0 (en) 2003-07-25 2003-07-25 Nicotinamide derivatives useful as PDE4 inhibitors

Publications (1)

Publication Number Publication Date
GB0317509D0 true GB0317509D0 (en) 2003-08-27

Family

ID=27772736

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0317509.8A Ceased GB0317509D0 (en) 2003-07-25 2003-07-25 Nicotinamide derivatives useful as PDE4 inhibitors

Country Status (7)

Country Link
EP (1) EP1651647A1 (en)
JP (1) JP2006528623A (en)
BR (1) BRPI0412933A (en)
CA (1) CA2533681A1 (en)
GB (1) GB0317509D0 (en)
MX (1) MXPA06000988A (en)
WO (1) WO2005010001A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR049384A1 (en) 2004-05-24 2006-07-26 Glaxo Group Ltd PURINA DERIVATIVES
PT1888033E (en) * 2005-06-09 2014-05-15 Meda Ab Method and composition for treating inflammatory disorders
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
AU2006278573A1 (en) * 2005-08-03 2007-02-15 Immunogen, Inc. Immunoconjugate formulations
EP2297106B1 (en) * 2008-05-27 2014-07-16 AstraZeneca AB Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL336148A1 (en) * 1997-04-04 2000-06-05 Pfizer Prod Inc Nicotinamide derivatives
GB0203193D0 (en) * 2002-02-11 2002-03-27 Pfizer Ltd Nicotinamide derivatives useful as pde4 inhibitors
RS70104A (en) * 2002-02-11 2007-02-05 Pfizer Limited, Nicotinamide derivatives useful as pde4 inhibitors

Also Published As

Publication number Publication date
MXPA06000988A (en) 2006-04-11
EP1651647A1 (en) 2006-05-03
WO2005010001A1 (en) 2005-02-03
JP2006528623A (en) 2006-12-21
BRPI0412933A (en) 2006-09-26
CA2533681A1 (en) 2005-02-03

Similar Documents

Publication Publication Date Title
PL372756A1 (en) Nicotinamide derivatives useful as pde4 inhibitors
IL172793A0 (en) Nicotinamide derivatives useful as pde4 inhibitors
PL373146A1 (en) Pyridazinone-derivatives as pde4 inhibitors
HK1118274A1 (en) Quinoline derivatives as phosphodiesterase inhibitors
GB0203193D0 (en) Nicotinamide derivatives useful as pde4 inhibitors
IL179280A0 (en) Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors
HK1071360A1 (en) 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
AU2003255376A1 (en) Piperidine-derivatives as pde4 inhibitors
IL172375A0 (en) Chinazoline derivatives as aurora kinase inhibitors
GB0317516D0 (en) Nicotinamide derivatives useful as PDE4 inhibitors
GB0317484D0 (en) Nicotinamide derivatives useful as pde4 inhibitors
GB0317482D0 (en) Nicotinamide derivatives useful as pde4 inhibitors
GB0317509D0 (en) Nicotinamide derivatives useful as PDE4 inhibitors
GB0317472D0 (en) Nicotinamide derivatives useful as PDE4 inhibitors
AU2003232362A8 (en) 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors
GB0224453D0 (en) Nicotinamide derivatives useful as PDE4 inhibitors
GB0203196D0 (en) Nicotinamide derivatives useful as pde4 inhibitors
GB0220999D0 (en) Nicotinamide derivatives useful as pde4 inhibitors
GB0227139D0 (en) Nicotinamide derivatives useful as pde4 inhibitors
PL376540A1 (en) Diazepanes derivatives useful as lfa inhibitors
IS7366A (en) Nicotinamide derivatives useful as PDE4 inhibitors
DOP2003000586A (en) USEFUL NICOTINAMIDE DERIVATIVES AS PDE4 INHIBITORS
AU2003207639A1 (en) Pyrimidine derivatives as rho-kinase inhibitors

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)